<DOC>
	<DOCNO>NCT02262585</DOCNO>
	<brief_summary>Study investigate bioequivalence BIBR 277 tablet ( Mannitol base ) vs. BIBR 277 capsule</brief_summary>
	<brief_title>Bioequivalence BIBR 277 Tablet ( Mannitol Based ) Compared With Capsule Formulation Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Mannitol</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>1 . Age &gt; = 20 &lt; = 35 year 2 . Weight : BMI &gt; 17.6 &lt; 26.4 ( Weight ( kg ) / Height ( ) 2 ) 3 . Subjects judge investigator eligible study subject , clinically significant finding screen 4 . Subjects volunteer participate able fully understand agree study write informed consent 1 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 2 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 3 . Chronic relevant acute infection 4 . History hepatic disorder ( e.g. , biliary cirrhosis , cholestasis ) 5 . History serious renal disorder 6 . History present bilateral renal artery stenosis lack unilateral kidney accompany arterial stenosis 7 . History present cerebrovascular disorder 8 . History hyperkalemia 9 . History hypersensitivity active ingredient ( Telmisartan ) angiotensin II receptor antagonists 10 . History present orthostatic hypotension faint 11 . Surgery gastrointestinal tract ( except appendectomy ) 12 . History alcohol drug abuse 13 . Participation another trial investigational drug within 4 month prior trial 14 . Whole blood donation 400 mL within 3 month prior trial 15 . Whole blood donation 100 mL within 1 month prior trial 16 . Donation constituent blood 400 mL within 1 month prior trial 17 . Any medication might influence result trial within 10 day prior trial 18 . Excessive physical activity within 7 day prior trial 19 . Alcohol drinking within 3 day prior trial 20 . Inability comply restriction protocol 21 . Other , judged investigator inappropriate subject study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>